CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Medigard Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Medigard Ltd
Shop 14 30 Tedder Ave, Main Beach
Phone: +61 755787822p:+61 755787822 Gold Coast, QLD  4217  Australia Fax: +61 755284459f:+61 755284459

This company is no longer actively traded on any major stock exchange.

Business Summary
Medigard Limited is engaged in the development of medical instruments in Australia. The principal activities of the Company are liaising with Shanghai Sol-Millennium Medical Products Co., Ltd for the improvement of the Blood Collection Device; bundling of the Blood Collection Device with its Flash Back Needle, and the progressing and maintenance of patents. It designs and manufactures a range of products, including Auto-retractable Syringe and Manual Retractable Syringe. The Company offers its products for healthcare workers and their patients. Its Blood Collection Device features vacuum technology to capture the needle after blood has been collected. Its Flash Back Needle allows healthcare workers immediate visual confirmation of a venipuncture. The Company's Intravenous Valve operates as a component of the cannula and a standalone device, which is used as access points in the catheters in preference to a syringe for delivering fluid, administering drugs and taking blood samples.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20206/30/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Christopher J.Bishop 10/20/2017 9/1/2008
Chief Financial Officer, Company Secretary Patricia M.Boero 3/17/2011 1/1/2004
Director Craig D.Cameron 11/25/2016 11/25/2016
Director IanDixon 11/21/2017 11/21/2017

Business Names
Business Name
Medigard Limited
MGZ

General Information
Outstanding Shares: 172,468,036 (As of 6/30/2020)
Shareholders: 723
Stock Exchange: ASX
Fax Number: +61 755284459


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 1, 2024